Commensal-bacteria-derived butyrate promotes the T-cell-independent IgA response in the colon.


Journal

International immunology
ISSN: 1460-2377
Titre abrégé: Int Immunol
Pays: England
ID NLM: 8916182

Informations de publication

Date de publication:
12 04 2020
Historique:
received: 07 11 2019
accepted: 19 12 2019
pubmed: 21 12 2019
medline: 2 10 2020
entrez: 21 12 2019
Statut: ppublish

Résumé

Secretory immunoglobulin A (SIgA), the most abundant antibody isotype in the body, maintains a mutual relationship with commensal bacteria and acts as a primary barrier at the mucosal surface. Colonization by commensal bacteria induces an IgA response, at least partly through a T-cell-independent process. However, the mechanism underlying the commensal-bacteria-induced T-cell-independent IgA response has yet to be fully clarified. Here, we show that commensal-bacteria-derived butyrate promotes T-cell-independent IgA class switching recombination (CSR) in the mouse colon. Notably, the butyrate concentration in human stools correlated positively with the amount of IgA. Butyrate up-regulated the production of transforming growth factor β1 and all-trans retinoic acid by CD103+CD11b+ dendritic cells, both of which are critical for T-cell-independent IgA CSR. This effect was mediated by G-protein-coupled receptor 41 (GPR41/FFA3) and GPR109a/HCA2, and the inhibition of histone deacetylase. The butyrate-induced IgA response reinforced the colonic barrier function, preventing systemic bacterial dissemination under inflammatory conditions. These observations demonstrate that commensal-bacteria-derived butyrate contributes to the maintenance of the gut immune homeostasis by facilitating the T-cell-independent IgA response in the colon.

Identifiants

pubmed: 31858119
pii: 5681570
doi: 10.1093/intimm/dxz078
doi:

Substances chimiques

Butyrates 0
Immunoglobulin A 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

243-258

Informations de copyright

© The Japanese Society for Immunology. 2019. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Auteurs

Junya Isobe (J)

Division of Biochemistry, Faculty of Pharmacy and Graduate School of Pharmaceutical Science, Keio University, Tokyo, Japan.

Shintarou Maeda (S)

Division of Biochemistry, Faculty of Pharmacy and Graduate School of Pharmaceutical Science, Keio University, Tokyo, Japan.

Yuuki Obata (Y)

Division of Biochemistry, Faculty of Pharmacy and Graduate School of Pharmaceutical Science, Keio University, Tokyo, Japan.
International Research and Development Center for Mucosal Vaccines, Institute of Medical Science, University of Tokyo (IMSUT), Tokyo, Japan.

Keito Iizuka (K)

Division of Biochemistry, Faculty of Pharmacy and Graduate School of Pharmaceutical Science, Keio University, Tokyo, Japan.

Yutaka Nakamura (Y)

Division of Biochemistry, Faculty of Pharmacy and Graduate School of Pharmaceutical Science, Keio University, Tokyo, Japan.

Yumiko Fujimura (Y)

Division of Biochemistry, Faculty of Pharmacy and Graduate School of Pharmaceutical Science, Keio University, Tokyo, Japan.

Tatsuki Kimizuka (T)

Division of Biochemistry, Faculty of Pharmacy and Graduate School of Pharmaceutical Science, Keio University, Tokyo, Japan.

Kouya Hattori (K)

Division of Biochemistry, Faculty of Pharmacy and Graduate School of Pharmaceutical Science, Keio University, Tokyo, Japan.

Yun-Gi Kim (YG)

Research Center for Drug Discovery, Faculty of Pharmacy, Keio University, Tokyo, Japan.

Tatsuya Morita (T)

Department of Applied Biological Chemistry, Graduate School of Agriculture, University of Shizuoka, Shizuoka, Japan.

Ikuo Kimura (I)

Department of Applied Biological Science, Graduate School of Agriculture, Tokyo University of Agriculture and Technology, Tokyo, Japan.

Stefan Offermanns (S)

Department of Pharmacology, Max-Plank-Institute for Heart and lung Research, Berlin, Germany.

Takahiro Adachi (T)

Department of Immunology, Tokyo Medical and Dental University, Tokyo, Japan.

Atsuhito Nakao (A)

Faculty of Medicine, University of Yamanashi, Yamanashi, Japan.

Hiroshi Kiyono (H)

International Research and Development Center for Mucosal Vaccines, Institute of Medical Science, University of Tokyo (IMSUT), Tokyo, Japan.

Daisuke Takahashi (D)

Division of Biochemistry, Faculty of Pharmacy and Graduate School of Pharmaceutical Science, Keio University, Tokyo, Japan.

Koji Hase (K)

Division of Biochemistry, Faculty of Pharmacy and Graduate School of Pharmaceutical Science, Keio University, Tokyo, Japan.
International Research and Development Center for Mucosal Vaccines, Institute of Medical Science, University of Tokyo (IMSUT), Tokyo, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH